Testing for ‘Bad Cholesterol’ Doesn’t Tell the Whole Story

For decades, assessing cholesterin hazard has been built astir a elemental idea: Lower “bad” cholesterol, little your accidental of a bosom attack. The trial astatine the halfway of that attack measures however overmuch low-density lipoprotein, oregon LDL cholesterol, is circulating successful portion of the blood. It has shaped everything from objective guidelines to the wide usage of statins, medications that trim LDL.

It works. Lowering LDL cholesterin reduces bosom attacks, strokes, and aboriginal death. But it doesn’t archer the full story.

The LDL cholesterin trial measures the magnitude of cholesterin wrong the low-density lipoprotein particles circulating successful the bloodstream. Those LDL particles containing the cholesterin tin get trapped successful artery walls, forming plaques that tin yet artifact humor flow. As the trial measures the magnitude of cholesterin being carried, not the fig of LDL particles themselves, 2 radical tin person the aforesaid LDL cholesterin level but precise antithetic numbers of particles, and truthful antithetic levels of risk.

That spread has pushed researchers toward a antithetic mode of measuring risk. Apolipoprotein B, oregon apoB, reflects the full fig of cholesterol-carrying particles successful the humor alternatively than however overmuch cholesterin they contain. A increasing assemblage of probe suggests it’s a much close mode of identifying who is astatine hazard and who’s not.

In March 2026, the American Heart Association and American College of Cardiology recognized this. Their updated cholesterin guidelines acknowledged apoB arsenic a perchance much precise marker, successful enactment with earlier European recommendations. But they stopped abbreviated of recommending apoB arsenic the superior method for testing.

“They reappraisal the grounds and fertile apoB arsenic superior, but the existent rules of the roadworthy proceed to prioritize LDL,” says Allan Sniderman, a cardiologist astatine McGill University.

Sniderman was an writer connected a 2026 JAMA modeling survey that analyzed beingness outcomes for astir 250,000 US adults eligible for statin treatment. Comparing LDL cholesterol, non-HDL cholesterol, and apoB, the survey recovered that utilizing apoB to usher attraction decisions would forestall much bosom attacks and strokes than existent approaches, portion remaining cost-effective.

ApoB investigating tin beryllium done done modular humor tests. So wherefore has it not filtered into regular care? Not adjacent successful Europe, wherever the guidelines person reflected its usefulness for years.

Part of the reply is inertia. For decades, LDL cholesterin has been some a technological breakthrough and a nationalist wellness occurrence story. It is simple, wide understood, and straight linked to treatments that work.

“For 50 years, LDL cholesterin was an astonishing discovery,” Sniderman says. “It’s not that it isn’t a bully marker. It is simply a bully marker.”

Børge Nordestgaard, president of the European Atherosclerosis Society, agrees that LDL cholesterin remains cardinal for a reason. “The grounds is immense; it’s beyond discussion,” helium says. “Statins trim bosom attacks, strokes, and aboriginal decease done LDL cholesterin lowering.”

That occurrence helped signifier a almighty narrative: LDL is “bad cholesterol,” and lowering it saves lives. But that simplicity has besides constricted however hazard is understood.

“The effect is patients and physicians cognize small oregon thing astir apoB,” Sniderman says.

More caller probe suggests that the cholesterin representation is much complex, particularly successful radical already taking statins. Previous studies led by Nordestgaard person shown that successful treated patients, precocious levels of apolipoprotein B and non-HDL cholesterin stay associated with accrued hazard of bosom attacks and mortality, portion LDL cholesterin does not. ApoB, successful particular, emerged arsenic the astir close marker.

For Kausik Ray, a cardiologist astatine Imperial College London, the situation is not choosing 1 marker implicit another, but knowing what each 1 captures, and what it misses.

“We’re not funny successful cholesterin for its ain sake,” Ray says. “We’re trying to forestall bosom attacks and strokes.”